Seyed Hossein Shahcheraghi | Molecular Pharmacology | Innovative Molecular Biologist Award

Published on by Molecular Biologist

Innovative Molecular Biologist Award

Seyed Hossein Shahcheraghi
Yazd Shahid Sadoughi University of Medical Sciences Campus, Iran

Seyed Hossein Shahcheraghi
Affiliation Yazd Shahid Sadoughi University of Medical Sciences Campus
Country Iran
Scopus ID 55935316300
Documents 75
Citations 820
h-index 13
Subject Area Molecular Pharmacology
Event International Molecular Biologist Awards
ORCID 0000-0003-1399-5222

Seyed Hossein Shahcheraghi is a researcher affiliated with Yazd Shahid Sadoughi University of Medical Sciences Campus in Iran, with a stated subject-area focus in molecular pharmacology. These bibliometric indicators provide a quantitative overview of the research record and are presented here as profile information rather than as an independent assessment of scientific quality.[1] [2]

Abstract

This academic recognition profile presents the research record of Seyed Hossein Shahcheraghi, affiliated with Yazd Shahid Sadoughi University of Medical Sciences Campus, Iran. The stated research subject area is molecular pharmacology, a field concerned with molecular and cellular mechanisms underlying pharmacological activity, drug action, and therapeutic response. The available Scopus profile reports 75 documents, 820 citations, and an h-index of 13.[1] The profile is additionally associated with ORCID identifier 0000-0003-1399-5222.[2] On the basis of the supplied bibliometric information and stated research area, the researcher is presented in connection with the Innovative Molecular Biologist Award under the International Molecular Biologist Awards.

Keywords

Keywords: Seyed Hossein Shahcheraghi; Molecular Pharmacology; Molecular Biology; Pharmacology; Biomedical Research; Research Impact; Bibliometrics; Scopus; ORCID; Innovative Molecular Biologist Award.

Introduction

Molecular pharmacology examines pharmacological phenomena at the molecular and cellular levels, linking biological mechanisms with the actions of drugs and other bioactive compounds. Modern pharmacological research increasingly incorporates molecular targets, signaling pathways, cellular responses, and mechanisms that influence therapeutic activity. The identification and characterization of molecular targets are consequently important components of contemporary drug discovery and pharmacological investigation.[4]

Within this broader scientific context, the research profile of Seyed Hossein Shahcheraghi is identified with molecular pharmacology and is associated with Yazd Shahid Sadoughi University of Medical Sciences Campus in Iran. The bibliographic indicators supplied for the profile provide a measurable description of publication activity and citation influence within indexed scholarly literature.[1]

Research Profile

The researcher’s stated subject area is Molecular Pharmacology. The supplied Scopus information identifies the researcher with Author ID 55935316300 and records 75 documents, 820 citations, and an h-index of 13.[1] These values are bibliometric descriptors of the indexed research record and may change as additional publications and citations are incorporated into bibliographic databases.

  • Researcher: Seyed Hossein Shahcheraghi
  • Institution: Yazd Shahid Sadoughi University of Medical Sciences Campus
  • Country: Iran
  • Primary subject area: Molecular Pharmacology
  • Scopus documents: 75
  • Scopus citations: 820
  • h-index: 13
  • ORCID: 0000-0003-1399-5222

The ORCID identifier provides a persistent researcher identifier intended to support reliable attribution of scholarly works and distinguish researchers across systems.[2] Used alongside bibliographic identifiers such as Scopus Author ID, persistent identifiers can assist in organizing and validating scholarly records.

Research Contributions

The available information places Shahcheraghi’s research within molecular pharmacology. At this level of description, the most appropriate characterization is a field-based one rather than a claim concerning a particular molecular pathway, therapeutic target, disease model, or individual discovery, because those details are not specified in the supplied researcher profile.

Molecular pharmacology encompasses the study of interactions between pharmacologically active molecules and biological systems. Research in this area may connect molecular targets with cellular mechanisms and pharmacological outcomes, contributing to the broader understanding of drug action and therapeutic development.[4] The researcher’s stated subject-area classification therefore provides the principal basis for describing the scientific domain represented in this recognition profile.

Publications

The supplied bibliometric record reports 75 documents indexed under the researcher’s Scopus Author ID. This publication count represents the document total provided for the profile at the time of preparation and should be understood as a database-derived indicator rather than a complete independent bibliography of every scholarly work associated with the researcher.[1]

A publication-level assessment would ordinarily examine article titles, journals, publication dates, co-authorship, citation patterns, research topics, and persistent identifiers such as DOI records. No individual publication list or researcher-specific DOI information was supplied for this page; therefore, no specific article is attributed to Shahcheraghi without an independently verified bibliographic record.

Research Impact

The supplied Scopus profile reports 820 citations and an h-index of 13.[1] Citation counts provide one quantitative measure of how frequently indexed scholarly documents have been cited, while the h-index combines publication and citation information into a single bibliometric indicator. Such measures are useful for describing research visibility but do not, by themselves, establish the quality, originality, or practical significance of individual research contributions.

The reported document and citation figures provide a quantitative basis for recognizing an established publication record within indexed literature. They should nevertheless be interpreted in relation to disciplinary practices, publication age, database coverage, authorship patterns, and other qualitative evidence when making a comprehensive assessment of research influence.

Award Suitability

The profile is presented in connection with the Innovative Molecular Biologist Award under the International Molecular Biologist Awards. The stated field of Molecular Pharmacology provides a direct connection to molecular-level biological research, while the reported Scopus record supplies quantitative evidence of sustained scholarly publication and citation activity.[1]

On the information provided, the recognition profile can be framed around three principal elements: an identified academic affiliation, a defined molecular pharmacology subject area, and a documented bibliometric record. The award suitability statement is therefore descriptive of the supplied profile and does not constitute an independent peer-review judgment or a claim of comparative superiority over other researchers.

Conclusion

Seyed Hossein Shahcheraghi is identified with Yazd Shahid Sadoughi University of Medical Sciences Campus, Iran, and with the research area of Molecular Pharmacology. The supplied Scopus profile reports 75 documents, 820 citations, and an h-index of 13, while ORCID provides the persistent identifier 0000-0003-1399-5222.[1] [2]

These identifiers and bibliometric indicators establish the principal factual basis of this academic recognition page. In the context of the International Molecular Biologist Awards, the profile supports presentation under the Innovative Molecular Biologist Award while maintaining a distinction between documented bibliometric information and broader qualitative judgments concerning scientific achievement.

References

  1. Elsevier. (n.d.). Scopus author details: Seyed Hossein Shahcheraghi, Author ID 55935316300. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=55935316300
  2. ORCID. (n.d.). Seyed Hossein Shahcheraghi — ORCID record. ORCID.
    https://orcid.org/0000-0003-1399-5222
  3. International Molecular Biologist Awards. (n.d.). International Molecular Biologist Awards.
    https://molecularbiologist.org/
  4. Santos, R., Ursu, O., Gaulton, A., Bento, A. P., Donadi, R. S., Bologa, C. G., Karlsson, A., Al-Lazikani, B., Hersey, A., Oprea, T. I., & Overington, J. P. (2017). A comprehensive map of molecular drug targets. Nature Reviews Drug Discovery, 16, 19–34.
    https://doi.org/10.1038/nrd.2016.230
  5. Molecular pharmacology and drug-target research. DOI-linked scholarly literature concerning molecular drug targets and pharmacological mechanisms.
    https://doi.org/10.1038/nrd.2016.116

Yong-Xiao Wang | Drug Discovery Research | Best Researcher Award

Published on by Molecular Biologist

Dr. Yong-Xiao Wang | Drug Discovery Research | Best Researcher Award 

Principal Investigator, at Albany Medical College, United States.

Dr. Yong-Xiao Wang is a distinguished professor in Molecular & Cellular Physiology at Albany Medical College. With a profound dedication to cardiovascular and respiratory research, he has become a key figure in exploring molecular mechanisms within these fields. His research examines cell calcium signaling, ion channels, and reactive oxygen species in cardiovascular and respiratory systems. Dr. Wang has garnered substantial funding through NIH and AHA grants, contributing to groundbreaking discoveries in cellular signaling pathways. A prolific author, he has published extensively in high-impact journals, such as Nature and Proceedings of the National Academy of Sciences. Dr. Wang also actively participates in scientific editorial boards and professional societies, embodying a deep commitment to advancing translational medicine and mentoring future leaders in physiology and pharmacology.

Profile

Scopus

Education 🎓

Dr. Wang completed his M.D. equivalent in 1983 from Wannan Medical College, China, setting the foundation for his medical and scientific journey. He pursued advanced studies at the Fourth Military Medical University in Xian, earning his M.S. in 1986 and later a Ph.D. in 1990. This robust academic background enabled him to acquire deep insights into pharmacology and physiology, essential for his focus on cardiovascular and respiratory biology. His education honed his expertise in molecular biology, with an emphasis on cell signaling mechanisms and regulatory pathways, forming the basis for his impactful research career in molecular and cellular physiology.

Experience 📚

Dr. Wang’s professional trajectory spans several decades and prestigious institutions. He has served as a tenured professor at Albany Medical College since 2006. Previously, he held roles as an associate professor and senior research associate at Cornell University and the University of Pennsylvania, where he gained extensive research experience. Early in his career, Dr. Wang held positions at the Fourth Military Medical University in China. His multifaceted experience encompasses research, teaching, and mentorship, reinforcing his expertise in translational medicine and his commitment to innovation in cardiovascular and respiratory sciences.

Research Interests 🔬

Dr. Wang’s research focuses on cardiovascular and respiratory biology, particularly investigating cellular signaling mechanisms. His studies delve into calcium signaling, ion channels, reactive oxygen species, and neurotransmitter receptors in cardiovascular and respiratory systems. Dr. Wang employs molecular, biochemical, and pharmacological approaches to understand these processes, aiming to uncover therapeutic pathways for heart and lung diseases. His translational research bridges cellular mechanisms and clinical applications, aiming to develop novel therapies for conditions such as pulmonary hypertension and cardiac hypertrophy, underscoring his commitment to advancing human health.

Awards 🏆

Dr. Wang has been recognized widely for his contributions to medical research. His accolades include the American Heart Association’s Established Investigator Award in 2003 and the Scientist Development Award in 1998. In 2020, he was elected a Fellow of the American Physiology Society, reflecting his influence in the field. Additionally, he has received Outstanding Research Awards from the Chinese Heart Association and Chinese Pharmacology Society, acknowledging his research impact across both national and international platforms. Dr. Wang’s awards highlight his consistent excellence in cardiovascular and respiratory research.

Top Noted Publications 📑

Dr. Wang has authored numerous influential publications in high-impact journals, reflecting his extensive contributions to cardiovascular and respiratory research. Key publications include:

  • “Effects of doxorubicin on excitation-contraction coupling in guinea-pig ventricular myocardium”
    Published in Circulation Research, 1995

    • This study explores the cellular mechanisms by which doxorubicin, a chemotherapeutic agent, affects heart muscle contraction. It investigates the impact on excitation-contraction coupling in guinea pig ventricular myocardium, shedding light on the cardiovascular side effects of doxorubicin treatment.
    • Cited by: 500+ articles
  • “Oestrogen protects FKBP12.6 null mice from cardiac hypertrophy”
    Published in Nature, 2002

    • This research delves into the protective role of oestrogen in preventing cardiac hypertrophy in FKBP12.6 null mice. The study highlights the significance of estrogen in modulating cardiac function and its potential therapeutic implications in preventing heart enlargement and dysfunction.
    • Cited by: 1000+ articles
  • “Rieske iron-sulfur protein induces remodeling of FKBP12.6/RyR2 complex”
    Published in Nature Communications, 2020

    • This paper examines the role of the Rieske iron-sulfur protein in the remodeling of the FKBP12.6/RyR2 complex, a critical component of the calcium release channel in cardiac muscle cells. This work helps to understand the molecular basis of arrhythmias and cardiac dysfunction.
    • Cited by: 200+ articles

Conclusion

Dr. Yong-Xiao Wang is a highly qualified candidate for the Research for Best Researcher Award. His significant contributions to the understanding of molecular mechanisms in respiratory and cardiovascular diseases, along with his extensive publication record, grant achievements, and leadership in academia, underscore his suitability for this recognition. With continued focus on interdisciplinary research and public health applications, Dr. Wang’s influence in the biomedical sciences could become even more impactful, making him a compelling choice for this award.